Parkinsonian Disorders

"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Descriptor ID	D020734
MeSH Number(s)	C10.228.140.079.862 C10.228.662.600
Concept/Terms	Parkinsonian Disorders Parkinsonian Disorders Parkinsonian Syndrome Parkinsonism Parkinsonian Syndromes Parkinsonian Diseases Autosomal Dominant Parkinsonism Autosomal Dominant Parkinsonism Dominant Parkinsonism, Autosomal Parkinsonism, Autosomal Dominant Autosomal Recessive Juvenile Parkinson Disease Autosomal Recessive Juvenile Parkinson Disease Chromosome 6-Linked Autosomal Recessive Parkinsonism Chromosome 6 Linked Autosomal Recessive Parkinsonism Familial Parkinson Disease, Autosomal Recessive Juvenile Parkinson Disease, Autosomal Recessive Juvenile Parkinsonism, Autosomal Recessive Parkinsonism, Early Onset, with Diurnal Fluctuation Parkinsonism, Juvenile, Autosomal Recessive Parkinson Disease 2, Autosomal Recessive Juvenile Parkinsonism, Early-Onset, With Diurnal Fluctuation Parkinson Disease, Juvenile, Autosomal Recessive Parkinson Disease 2 Parkinson Disease Autosomal Recessive, Early Onset Autosomal Recesssive Juvenile Parkinsonism Parkinson Disease, Familial, Autosomal Recessive Ramsay Hunt Paralysis Syndrome Ramsay Hunt Paralysis Syndrome Familial Juvenile Parkinsonism Familial Juvenile Parkinsonism Juvenile Parkinsonism, Familial Parkinsonism, Familial Juvenile Parkinsonism, Experimental Parkinsonism, Experimental Experimental Parkinsonisms Parkinsonisms, Experimental Parkinson Disease, Experimental Experimental Parkinsonism, MPTP-Induced Experimental Parkinsonism, MPTP Induced Parkinsonism, MPTP-Induced Experimental MPTP-Induced Experimental Parkinsonism MPTP Induced Experimental Parkinsonism Experimental Parkinson Disease Diseases, Experimental Parkinson Experimental Parkinson Diseases Parkinson Diseases, Experimental Experimental Parkinsonism Parkinsonism, Juvenile Parkinsonism, Juvenile Juvenile Parkinsonism Juvenile Parkinsonisms Parkinsonisms, Juvenile Parkinson Disease, Juvenile Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Juvenile Parkinson Disease, Autosomal Dominant Parkinsonism, Juvenile, Autosomal Dominant Parkinson Disease, Autosomal Dominant. Juvenile Parkinson Disease, Juvenile, Autosomal Dominant Autosomal Dominant Juvenile Parkinsonism Juvenile Parkinsonism, Autosomal Dominant Autosomal Recessive Parkinsonism Autosomal Recessive Parkinsonism Parkinsonism, Autosomal Recessive Recessive Parkinsonism, Autosomal

Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".

Diseases [C]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Basal Ganglia Diseases [C10.228.140.079]
Parkinsonian Disorders [C10.228.140.079.862]
Movement Disorders [C10.228.662]
Parkinsonian Disorders [C10.228.662.600]

Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.

Bar chart showing 12 publications over 8 distinct years, with a maximum of 3 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2006	1	0	1
2008	2	1	3
2009	1	1	2
2012	0	1	1
2014	1	0	1
2020	1	0	1
2021	2	0	2

Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.

Buck SA, De Miranda BR, Logan RW, Fish KN, Greenamyre JT, Freyberg Z. VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration. J Neurosci. 2021 06 02; 41(22):4937-4947.

View in: PubMed
Peters OM, Weiss A, Metterville J, Song L, Logan R, Smith GA, Schwarzschild MA, Mueller C, Brown RH, Freeman M. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease. Neurobiol Dis. 2021 07; 155:105368.

View in: PubMed
Apetauerova D, Hildebrand P, Scala S, Zani JW, Lipert L, Clark E, Fennell T, Gordon FD. A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis. Hepatol Commun. 2021 02; 5(2):323-333.

View in: PubMed
Ramirez-Zamora A, Gee L, Youn Y, Shin DS, Pilitsis JG. Pallidal Deep Brain Stimulation for the Treatment of Levodopa-Responsive Juvenile Dystonia and Parkinsonism Secondary to SPG11 Mutation. JAMA Neurol. 2017 01 01; 74(1):127-128.

View in: PubMed
Kaszuba BC, Walling I, Gee LE, Shin DS, Pilitsis JG. Effects of subthalamic deep brain stimulation with duloxetine on mechanical and thermal thresholds in 6OHDA lesioned rats. Brain Res. 2017 01 15; 1655:233-241.

View in: PubMed
O'Connor KA, Feustel PJ, Ramirez-Zamora A, Molho E, Pilitsis JG, Shin DS. Investigation of diazepam efficacy on anxiety-like behavior in hemiparkinsonian rats. Behav Brain Res. 2016 Mar 15; 301:226-37.

View in: PubMed
Gee LE, Chen N, Ramirez-Zamora A, Shin DS, Pilitsis JG. The effects of subthalamic deep brain stimulation on mechanical and thermal thresholds in 6OHDA-lesioned rats. Eur J Neurosci. 2015 Aug; 42(4):2061-9.

View in: PubMed
Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015 Jul; 14(7):710-9.

View in: PubMed
Phookan S, Sutton AC, Walling I, Smith A, O'Connor KA, Campbell JC, Calos M, Yu W, Pilitsis JG, Brotchie JM, Shin DS. Gap junction blockers attenuate beta oscillations and improve forelimb function in hemiparkinsonian rats. Exp Neurol. 2015 Mar; 265:160-70.

View in: PubMed
Sutton AC, O'Connor KA, Pilitsis JG, Shin DS. Stimulation of the subthalamic nucleus engages the cerebellum for motor function in parkinsonian rats. Brain Struct Funct. 2015 Nov; 220(6):3595-609.

View in: PubMed

People

Explore

Similar Concepts

Top Journals